The CXCL12/CXCR4 Axis Plays a Critical Role in Coronary Artery Development  by Ivins, Sarah et al.
Article
The CXCL12/CXCR4 Axis Plays a Critical Role in
Coronary Artery DevelopmentGraphical AbstractHighlightsd Cxcl12 and Cxcr4 mutants lack intra-ventricular coronary
arteries
d Coronary artery stem formation is impaired inCxcl12mutants
d Peritruncal blood vessels fail to penetrate the aortic
endothelium
d CXCL12 signaling is required for anastomosis of peritruncal
endothelial cellsIvins et al., 2015, Developmental Cell 33, 455–468
May 26, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.devcel.2015.03.026Authors
Sarah Ivins, Joel Chappell, ...,
Timothy J. Mohun, Peter J. Scambler
Correspondence
s.ivins@ucl.ac.uk
In Brief
Coronary artery stem formation depends
on the establishment of connections
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and the lumen of the developing aorta.
Ivins et al. have shown that in mice
deficient for the chemokine CXCL12, the
formation of such connections is
disrupted, leading to severe coronary
artery defects.
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The chemokine CXCL12 and its receptor CXCR4
have many functions during embryonic and post-
natal life. We used murine models to investigate the
role of CXCL12/CXCR4 signaling in cardiac develop-
ment and found that embryonic Cxcl12-null hearts
lacked intra-ventricular coronary arteries (CAs) and
exhibited absent or misplaced CA stems. We traced
the origin of this phenotype to defects in the early
stages of CA stem formation. CA stems derive from
the peritruncal plexus, an encircling capillary net-
work that invades the wall of the developing aorta.
We showed that CXCL12 is present at high levels in
the outflow tract, while peritruncal endothelial cells
(ECs) express CXCR4. In the absence of CXCL12,
ECs were abnormally localized and impaired in their
ability to anastomose with the aortic lumen. We pro-
pose that CXCL12 is required for connection of peri-
truncal plexus ECs to the aortic endothelium and
thus plays a vital role in CA formation.
INTRODUCTION
Formation of the coronary vascular system coincides with a
period of rapid expansion in cardiac size between embryonic
day (E) 11.5 and E13.5. Myocardial growth requires enhanced
oxygen delivery and triggers an influx of endothelial cells (ECs)
that undergo vasculogenesis to form a capillary plexus (Mikawa
and Fischman, 1992). Coronary ECs invade the myocardium
from a variety of sources, including the pro-epicardium (Katz
et al., 2012), endocardium (Wu et al., 2012), and sinus venosus
(Red-Horse et al., 2010; Tian et al., 2013b). Coronary lineage
tracing has been utilized in a recent study to shown both comple-
mentary (sinus venosus and endocardium) and cardiac-wide
(pro-epicardium) distribution of coronary ECs from these three
sources (Chen et al., 2014b). Extensive angiogenic remodeling
of the vascular plexus takes place from E14.5, giving rise to
the mature coronary vascular system (Kattan et al., 2004; Mora-
bito et al., 2002).DeveNormally, two major coronary arteries (CAs) arise from the
aorta, with their stems positioned at the left and right aortic valve
sinuses. The origins of theCA stemswere first elucidated in avian
embryos, where it was found that they form from an ingrowth of
ECs into the aorta (Bogers et al., 1989; Waldo et al., 1990).
Further investigation showed that endothelial strands grow into
the aorta from a ring of capillaries encircling the outflow tract
(peritruncal plexus) and penetrate the aortic sinuses at multiple
sites. By mechanisms that are unknown so far, the peritruncal
vessels persist and remodel at only two of these sites, ultimately
forming the CA stems (Aikawa and Kawano, 1982; Ando et al.,
2004; Poelmann et al., 1993; Ratajska and Fiejka, 1999; Waldo
et al., 1990). This ingrowth model of CA stem formation has
recently been confirmed in mice (Tian et al., 2013a). The molec-
ular signals underlying CA stem and ostia formation have yet to
be fully elucidated, although factors such as vascular epidermal
growth factor (VEGF), fibroblast growth factor 2 (FGF-2), and
platelet-derived growth factor b (PDGFb) have been found to
be required (Tomanek et al., 2006, 2008; Van den Akker et al.,
2008), indicating that multiple growth factors and signaling mol-
ecules are involved in this tightly orchestrated process. In partic-
ular, a role for chemokine activity in directing ECmigration to the
aortic sinuses has been suggested (Waldo et al., 1990).
CXCL12 and the G-protein-coupled cell surface receptor
CXCR4 are a chemokine ligand and receptor pair that have
been shown to regulate cell behavior and migration in numerous
contexts (Kiefer and Siekmann, 2011; Teicher and Fricker,
2010). During development, CXCL12 drives migration of cells ex-
pressing CXCR4, including ECs (Li et al., 2013) and neural crest
(Belmadani et al., 2005; Escot et al., 2013; Theveneau et al.,
2010),while knockout studies have shown thatmice lacking either
CXCL12orCXCR4die inuteroorperinatally,with identical defects
in hematopoiesis and cerebellar development aswell as a cardiac
ventricular septal defect (VSD) (Nagasawa et al., 1996, Ma et al.,
1998, Tachibana et al., 1998, Zou et al., 1998). CXCL12-CXCR4
signaling hasbeen shown toplay a significant role in angiogenesis
in the gut (Ara et al., 2005; Tachibanaet al., 1998), kidney (Takaba-
take et al., 2009), and brain, indicative of an organ-specific role in
vascularization (Kiefer and Siekmann, 2011).
We have now identified a critical role for CXCL12-CXCR4
signaling in the development of CAs in mice. By examining the
hearts ofCxcl12 andCxcr4mutant embryos late in development,
we have uncovered a severe phenotype, with complete absencelopmental Cell 33, 455–468, May 26, 2015 ª2015 The Authors 455
Figure 1. Mutation of Cxcl12 Causes Severe CA Defects
(A–B’) Control (A) and Cxcl12/ (B and B’) E18.5 embryos; note the small size of the null embryo in (B) and the hemorrhagic appearance of the embryo in (B’).
(C and D) H&E-stained E18.5 heart sections; boxed areas in control (C) and Cxcl12 null (D) are shown enlarged to the right (boxes i and ii). Arrows in (i) indicate
intra-ventricular CAs; arrowheads in (ii) indicate dilated veins in the null.
(E and F) Frontal view of E18.5 Cxcl12+/ (E) and Cxcl12/ (F) hearts.
(G–I) Whole-mount SM22a antibody staining of CAs at E18.5. Arrow indicates left CA in a wild-type control (G); Cxcl12/ (H) and Cxcr4/ (I) hearts lack CAs.
(J–M’) Analysis of CAs in E18.5 heart sections: SM22a marks CAs, EMCN labels endocardium, and nuclei are counterstained with DAPI. CAs are indicated by
arrows in wild-type myocardium (J) but are absent in Cxcl12 null myocardium (J’). Control coronary ostia are positioned in the aortic valve sinuses (arrows in K).
Arrowhead in (K’) shows a single CA proximal to the aorta (Ao) in the null, asterisks indicate thickened aortic valve leaflets. Arrowheads in (L) indicate arteries in
(legend continued on next page)
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of intra-ventricular CAs and abnormalities in the number and po-
sition of coronary ostia. Detailed expression analysis and con-
focal microscopy in Cxcl12 mutants have enabled us to trace
the origins of the defects to the development of the peritruncal
plexus from which the CA stems originate. Our data suggest a
model whereby CXCL12 secreted by cells of the aortic wall
acts as a chemoattractant for CXCR4-positive peritruncal ECs
and is required for anastomosis of peritruncal ECswith the lumen
of the aorta. Impairment of this process in Cxcl12 or Cxcr4 mu-
tants results in failure of arterialization of the main coronary
plexus.
RESULTS
Severe Defects in CA Development in Cxcl12- and
Cxcr4-Mutant Hearts
We carried out interbreeding of Cxcl12 heterozygous animals in
order to investigate the cardiovascular phenotype of Cxcl12 null
embryos. Despite the reported 50% lethality of Cxcl12 mutation
at E18.5 (Nagasawa et al., 1996), we were able to recover viable
mutant embryos at this stage at approximately Mendelian ratios.
Cxcl12mutants were stunted in growth to a variable degree, and
a number of them showed evidence of hemorrhaging (compare
Figure 1A with Figures 1B and 1B’). Furthermore, the hearts of
all mutant embryos appeared pale and enlarged compared to
those of controls (Figures 1E and 1F). H&E staining of mutant
heart sections showed a lack of large vessels in the Cxcl12/
ventricular myocardial wall and the presence of dilated veins
(compare Figures 1C and 1D).
In order to visualize coronary vessels more clearly, whole
E18.5 control and Cxcl12mutant hearts were stained for smooth
muscle expression using anti-SM22a antibody (Figures 1G and
1H). Strikingly, we observed that left and right CAs were not
visible in any Cxcl12 mutants (Figure 1H; Figures S1A–S1C).
An identical phenotype was observed in Cxcr4 mutant hearts
(Figure 1I). Coronary veins were present in Cxcl12 mutants (Fig-
ures S1A–S1C) and inCxcr4mutants (data not shown). Thus, the
most severe coronary vessel defects in theCxcl12/Cxcr4mutant
hearts appeared to be artery specific. Immunolabeling of sec-
tions confirmed the absence of CAs in E18.5 Cxcl12 mutant
hearts in the ventricular walls (compare Figures 1J and 1J’)
and inter-ventricular septum (IVS) (Figures 1L and 1L’). Although
single CAs proximal to the aorta were observed in Cxcl12 mu-
tants, ostia were not located in the normal position in the aortic
valve sinuses (compare Figures 1K and 1K’). We noted that these
abnormal proximal CAs were blood filled and patent to ink in a
further set of mutants (data not shown). Staining for the widely
expressed endothelial marker PECAM revealed the presence
of a comparatively normal capillary plexus in null hearts, albeit
lacking larger vessels (compare Figures 1M and 1M’), showing
that the lack of well-developed CAs in Cxcl12 null hearts cannot
be attributed to a lack of ECs in the myocardium.control IVS; inset shows enlargement of one artery; null IVS (L’) lacks vessels and a
control and Cxcl12/ hearts. EMCN, endomucin; LV, left ventricle; RV, right ven
(N–O’) HREMon E17.5 hearts. (N) shows 3D reconstructions (Imaris) of control and
ostia, and dashed lines indicate the top of aortic valve (AoV) leaflets. A single os
(O and O’) show thickened left and right AoV leaflets (L and R, respectively) in th
Scale bars represent 250 mm in (C) and (D) and 100 mm in (J)–(M). See also Figur
DeveThe aortic valve leaflets also appeared profoundly abnormal in
Cxcl12 mutants (Figure 1K’). In order to visualize the artery and
valve defects more clearly, high-resolution episcopic micro-
scopy (HREM) (Mohun and Weninger, 2012) was carried out on
Cxcl12 null (n = 3) and wild-type (n = 3) hearts (Figures 1N–1O’;
Movie S1). In the null hearts, the aortic valve leaflets appeared
thickened and were positioned at differing levels within the aorta
(Figure 1O’). Similar defects were observed in the pulmonary
valves (Movie S1). Each HREM-examined null heart had a single,
distally positioned ostium, with a short section of proximal CA
that failed to branch into the ventricles and terminated in the
IVS (Figures 1N and S1D–S1H’; Movie S1). In one mutant heart,
the ostium was also displaced ventrally (Figure 1N). Thus, all
Cxcl12 null hearts examined combined a lack of distal CAs
with severe semi-lunar valve (SLV) defects and a failure of prox-
imal artery/CA stem formation on at least one side.
Expression of Cxcl12 and Cxcr4 during Cardiac
Vascularization
Given the CA phenotype described earlier, we wanted to
examine cardiac expression of both Cxcl12 and Cxcr4 in detail
from E11.5 onward. This developmental stage was selected as
hearts are avascular before E10.5, while E11.5 marks the begin-
ning of the expansion of the coronary plexus that reportedly
invades the ventricular myocardium from E12.5 to E14.5 (Red-
Horse et al., 2010; Tian et al., 2013b).
Expression of Cxcl12 and Cxcr4 was analyzed by carrying out
in situ hybridization on serial sections. At E11.5, Cxcl12 was
highly expressed in the wall of the outflow tract (OT) and at a
lower level in the ventricular walls and trabeculatedmyocardium,
while Cxcr4 expression was localized to the endocardial lining of
the OT and atrioventricular cushions (AVCs) as previously re-
ported (Sierro et al., 2007), (Figures 2A and 2A’). At E12.5, a num-
ber of vessels expressing Cxcr4were observed, restricted to the
myocardial layer of the ventricle walls and the peritruncal region
(Figures 2B’ and 2C’; data not shown). The sites ofCxcr4 expres-
sion correlated with the emerging intra-myocardial coronary
plexus (Tian et al., 2013b). Cxcr4 was also expressed in the
endothelium and underlying mesenchyme of the aortic and pul-
monary valves, as well as in the AV valves from E12.5 onward
(data not shown). High levels of Cxcl12 expression were seen
in the walls of the aorta and pulmonary trunk at this develop-
mental stage (Figure 2B), as well as in the left ventricle, with lower
levels in right ventricular myocardium (Figures 2B and 2C).
Expression of both genes was maintained at E13.5 (Figures
2D–2E’), with increasing numbers of Cxcr4-expressing vessels
observed in the ventricular myocardial walls by E14.5 (Fig-
ure 2G’). At E13.5, Cxcr4 expression was also detected in peri-
truncal ECs, coincidingwith a region of strongCxcl12 expression
in the aortic wall (Figures 2E and 2E’), while from E14.5 onward,
Cxcr4 expression was observed in the maturing CAs and ostia
(Figure 2F’; data not shown). Cxcl12 expression remained atppears necrotic. (M andM’) PECAMantibody staining shows vascular plexus in
tricle.
Cxcl12 null aorta walls (cut away); arrows and dashed circles indicate coronary
tium was observed in the null. Two-dimensional (2D) slices through the aorta
e null (O’).
e S1 and Movie S1.
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Figure 2. Endothelial Expression of Cxcr4 Is Required for Coronary Arteriogenesis
(A–G’) Cxcl12 and Cxcr4 expression in serial sections of E11.5–E14.5 wild-type hearts (in situ hybridization). (A and A’) Sagittal sections at E11.5. Arrow in (A)
indicates Cxcl12 in the inferior wall of the OT; arrowheads in (A’) showCxcr4 in the lining of OT and AVCs (bracketed). (B–C’) Transverse sections at E12.5. (B and
C)Cxcl12 is highly expressed in OT vessels and left ventricle (LV) and at a lower level in the right ventricle (RV). Arrows in (C’) indicateCxcr4-positive vessels in the
ventricular wall; dotted line in (C’) delineates ventricle wall. (D–E’) Sagittal sections at E13.5. Inset in (D’) shows enlargement of Cxcr4-positive vessels in the
ventricle wall (boxed); arrowheads in (E’) indicateCxcr4 expression in the peritruncal plexus (PtP); note strong aorticCxcl12 expression in the consecutive section
in (E). (F–G’) Transverse sections at E14.5. Arrows in (F’) indicate Cxcr4 in the maturing LCA and ostium. Boxed area shown enlarged in (G and G’) shows Cxcr4
and Cxcl12 expression in a large coronary vessel. Ao, aorta; PT, pulmonary trunk; tb, trabeculated myocardium.
(legend continued on next page)
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Figure 3. ECs in Cxcl12-Mutant Hearts Are
Normally Localized, but Fail to Downregu-
late CXCR4 at E16.5, while Loss of CXCR4
in the Smooth Muscle Lineage Does Not
Affect CA Development
(A–B’) In situ hybridization analysis shows that
Cxcr4 expression is unaltered in E14.5 Cxcl12/
myocardial vessels (A’) compared to control (A).
Arrowheads in (B) and (B’) indicate coronary ostia;
arrows indicate proximal CAs. LV, left ventricle;
Ao, aorta.
(C and C’) PECAM antibody staining shows that
ECs are localized normally inCxcl12/ ventricular
myocardium at E13.5. RV, right ventricle.
(D and D’) NOTCH1 expression in control and
Cxcl12/ hearts.
(E–G’) CXCR4/PECAM antibody labeling of E16.5
wild-type and Cxcl12/ heart sections; CXCR4 is
co-expressed with PECAM in all intra-myocardial
(myo) vessels in the null (E’–G’) in contrast to its
more restricted expression in the control (E–G).
Dotted lines delineate sub-epicardial (epi) and
intra-myocardial regions of ventricle wall.
(H and H’) Conditional deletion of Cxcr4 in the
smooth muscle lineage using SM22a-Cre does
not affect CA development. SM22a/EMCN/DAPI
labeling shows normal CAs (arrows) present in
E18.5 SM22a;Cxcr4fl/ heart sections in (H’).
Scale bars represent 100 mm. See also Figure S3.high levels in both aorta and ventricular myocardium at E14.5
(Figures 2F and 2G), decreasing at later stages (data not shown).
In addition, from E14.5, larger intra-myocardial vessels were
observed to express both Cxcr4 and Cxcl12 (Figures 2G and
2G’; data not shown).Cxcr4was not expressed in sub-epicardial
ECs or vessels at this or any of the stages examined.
Antibody labeling of OT sections confirmed the expression of
CXCR4 in peritruncal plexus ECs (Figures 2H–2K).While anti-PE-
CAM antibodies labeled ECs of the peritruncal plexus and aortic
lumen (Figure 2I), CXCR4 staining was restricted to peritruncal
ECs and aortic valve endothelium (Figure 2J). Co-staining of
E14.5 heart sections with CXCR4 and PECAM antibodies
corroborated the aforementioned in situ data, further showing
that ventricular expression of CXCR4 was confined to ECs local-
ized in the myocardium (Figures 2L–2N). By E16.5, CXCR4
expression was reduced or extinguished in most of the intra-
myocardial capillary plexus, being retained mainly in larger
vessels (Figures 2O–2Q; Figure 3E). Thus, CXCR4 expression
appeared to be linked to the re-modeling/maturation of the cor-
onary network, declining as larger vessels developed.(H–K) Transverse sections through wild-type E12.5 aorta. CXCR4/PECAM co-loca
the lack of CXCR4 expression in the endothelial lining of the aorta. Arrowheads
(L–Q) CXCR4/PECAM co-localization in intra-myocardial ECs. Insets show enl
myocardial (myo) compartments of ventricular wall. CXCR4 is expressed in myo
jections of confocal stacks). CXCR4 is reduced or absent in smaller myocardial
(R–V) Whole-mount SM22a staining of E16.5 Tie-2Cre;Cxcr4fl/ and control hear
heart. A more mildly affected conditional null (T) exhibited a truncated LCA (arro
Cre;Cxcr4fl/ ventricular myocardium.
Scale bars represent 100 mm. See also Figure S2.
DeveTo test whether deletion of Cxcr4 in the endothelial lineage
alone was sufficient to recapitulate the CA phenotype found in
Cxcl12/Cxcr4 mutants, we used the Tie2-Cre transgene and a
floxed Cxcr4 allele (Nie et al., 2004) (Figures 2R–2V). Of seven
E16.5 Tie2-Cre;Cxcr4fl/ embryos examined by whole-mount
SM22a immunolabeling, four were observed to display the
same severe CA phenotype as Cxcl12 and Cxcr4 nulls (Fig-
ure 2S). Two had a milder phenotype, with CAs that followed a
normal course over the left and right ventricles but that appeared
shorter and less branched than in control hearts (particularly the
left CA [LCA]; one example shown in Figure 2T), and one ap-
peared normal (data not shown). Sections from another severely
affected conditional null showed that, as well as lacking intra-
ventricular CAs (Figure 2V), SLV defects were also present, along
with a single, distally positioned ostium (Figures S2A’ and S2B’).
Thus, EC-specific deletion of Cxcr4 recapitulated the CA pheno-
type observed in Cxcl12 nulls.
As a proportion of the conditional mutants appeared to be less
severely affected than full nulls, we investigated the efficiency of
the Cre recombinase in Tie2-Cre;Cxcr4fl/ hearts at E15.5. In onelization is shown in endothelial cells of the peritruncal plexus (bracketed). Note
in (J) and (K) indicate aortic valve endothelium.
argements of boxed regions; dotted lines delineate sub-epicardial (epi) and
cardial, but not sub-epicardial, ECs at E14.5 (L–N, maximum intensity z-pro-
vessels at E16.5 (O–Q, arrowheads).
ts (ventral views). Null in (S) lacks CAs; arrow in (R) indicates LCA in a control
w). SM22a/EMCN/DAPI-labeled sections (U and V) show lack of CAs in Tie2-
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of four conditional null hearts examined by in situ hybridization,
strong Cxcr4 expression was still observed (Figure S2D), indi-
cating a failure of Cre-mediated recombination in the endothe-
lium. Therefore, inefficient recombination of the Cxcr4 floxed
allele by the Tie2-driven Cre recombinase likely explains the
reduced penetrance of the CA phenotype in the conditional nulls.
CA Maturation Failure in Cxcl12 Mutants Is Not Caused
by Defective EC Localization, Arterial Fate
Specification, or vSMC Recruitment
As described earlier, CXCR4 is expressed in ECs located within
the compact myocardium of the ventricles. ECs localized in the
ventricular myocardium are fated to form capillaries and arteries
rather than veins (Red-Horse et al., 2010; Tian et al., 2013b; Wu
et al., 2012). To investigate the possible mechanism(s) underly-
ing the failure of CA formation in the Cxcl12 nulls, we first exam-
ined the localization of Cxcr4-expressing ECs in Cxcl12 mutant
hearts. However, this was found to be normal, as determined
by in situ hybridization at E14.5 (compare Figures 3A and 3A’).
The main difference observed at this stage was the lack of any
larger bore vessels on the left side of the aorta (a single ostium
was observed on the right side) (compare Figures 3B and 3B’),
consistent with the defects we observed at later stages. Simi-
larly, immunolabeling with PECAM antibody at E13.5 (Figures
3C and 3C’) and E14.5 (data not shown) did not reveal abnormal-
ities in the distribution of coronary ECs throughout the myocar-
dial and sub-epicardial layers of Cxcl12 mutant hearts. Thus,
CXCL12-CXCR4 signaling is not required formyocardial invasion
by coronary ECs.
To test the possibility that the myocardially localized ECs were
not correctly specified for arterial differentiation, we used
NOTCH1 as a marker of arterial fate (del Monte et al., 2011).
However, we found that NOTCH1 was expressed normally in
Cxcl12 mutant hearts at E15.5 (Figures 3D and 3D’) and E16.5
(data not shown), consistent with correct arterial specification
of coronary ECs.
These data indicated that coronary ECs in Cxcl12mutants are
both correctly localized and specified for arterial differentiation;
therefore, the lack of CA formation is likely caused by the failure
of the coronary plexus to mature/re-model. Our observation that
CXCR4 expression becomes restricted mainly to larger coronary
vessels between E14.5 and E16.5 (Figures 2O–2Q) suggested
that CXCR4 levels may serve as an indicator of the state of matu-
ration of the coronary plexus. Therefore, we examined CXCR4
expression in Cxcl12 mutant hearts at E16.5 and found that, in
contrast to control hearts (Figures 3E–3G), small CXCR4/PECAM
co-stained vessels were visible throughout the myocardium of
mutant ventricles (Figures 3E’–3G’) and IVS (data not shown).
This was similar to the pattern observed in E14.5wild-type hearts
(Figure 2N), supporting the hypothesis that the vascular plexus is
retained in an immature state in mutant hearts. Quantification of
the number of ECs inmutant hearts confirmed the increase in the
proportion of CXCR4-expressing ECs but showed that there was
no difference in the overall number of ECs compared to controls
(data not shown).
Recruitment of mural cells (pericytes and vascular smooth
muscle cells [vSMCs]) to newly formed vessels is required to sta-
bilize, remodel, and mature the primary vasculature. As expres-
sion of CXCR4 has been reported in both pericytes and vSMC460 Developmental Cell 33, 455–468, May 26, 2015 ª2015 The Authoprogenitors (Song et al., 2009; Zernecke et al., 2005; Petit
et al., 2007), we wanted to examine the potential role of the
CXCR4/CXCL12 axis in the recruitment of mural cells to the cor-
onary vasculature. Therefore, SM22a-driven Cre recombinase
was used to inactivate Cxcr4 in vSMCs and pericytes (Anastasia
et al., 2014). However, CAs were found to have developed
normally in all conditional nulls examined at E18.5 (Figure 3H’;
n = 8), although a high percentage of SLV defects was observed
(87.5%of conditional nulls) (Figures S3A’ and S3B’). Coverage of
CAs with vSMCs (as analyzed using SM22a/PECAM expression)
was unaffected in SM22a-Cre;Cxcr4fl/ hearts (Figure S3C’).
Therefore, a lack of mural cell recruitment does not appear to
be the underlying cause of the failure of coronary plexus matura-
tion in Cxcl12 null hearts.
Confocal Analysis of Peritruncal Plexus Development
Another requirement for maturation of the intra-ventricular coro-
nary plexus is blood flow into the coronary ostia; development of
the tunica media of the arteries has been shown to proceed in a
proximo-distal direction at the onset of coronary flow (Ando
et al., 2004; Ratajska and Fiejka, 1999; Vrancken Peeters et al.,
1997). Therefore, defective development of the CA stems/ostia,
preventing blood flow into the coronary vessels, would abrogate
the maturation process. Absent coronary ostia in Cxcl12
null hearts coupled with expression of Cxcr4 and Cxcl12 in peri-
truncal ECs and aortic wall, respectively (discussed earlier) sug-
gest a potential role for CXCL12-CXCR4 signaling in CA stem
formation.
In order to better understand a potential role for CXCL12-
CXCR4 signaling in this process, we first made a detailed study
of peritruncal plexus formation from E11.5 onward, using
confocal microscopy of optically cleared whole-mount PE-
CAM-stained wild-type hearts. Previous studies have not inves-
tigated peritruncal plexus formation at murine developmental
stages prior to E12.5. At E11.5, we observed isolated clusters
of ECs in the dorsal part of the OT wall anterior to the cushions,
with multiple processes contacting the OT lumen (boxed region
in Figure 4A; Figure 5A). The only other coronary ECs observed at
this stagewere in the sub-epicardial region of the ventricles (data
not shown), consistent with previously reported observations
(Tian et al., 2013b). Therefore, peritruncal plexus formation pre-
cedes development of the main intra-myocardial coronary
plexus. By E12.5, the peritruncal plexus had expanded around
the proximal part of the aorta, anterior to the cushions; clusters
of interconnected EC strands were now observed on either
side of the aorta, located close to the lumen as well as in the
sub-epicardial compartment, again with multiple processes
forming anastomoses with the aortic lumen (Figures 4B and
5D). At this stage, the peritruncal plexus was still not continuous
with the developing intra-ventricular plexus, but inter-connecting
vessels were observed at the base of the aorta at a slightly later
stage (approximately E12.5–E13.0; arrows in Figure 4C). By
E13.5, the peritruncal plexus had taken on a more organized,
mature appearance, with some of the EC strands appearing
wider and lumenized (Figure S4A). Multiple points of contact
were still retained between the EC strands and both sides of
the aortic lumen at various points level with, and distal to,
the aortic valve, as previously described (Ando et al., 2004;
Poelmann et al., 1993; Ratajska and Fiejka, 1999; Tian et al.,rs
Figure 4. Development of the Peritruncal
Plexus
(AC) Confocal microscopic images of whole-
mount PECAM-labeled hearts (maximum intensity z
projections of confocal stacks) showing develop-
ment of the peritruncal plexus from E11.5 to E13.0.
Inset in (A) is an enlargement of the boxed region,
showing processes from an EC cluster contacting
theOT lumenatE11.5.AtE12.0 (B)andE12.5–E13.0
(C), the peritruncal plexus is seen on both sides of
the aorta (Ao), just distal to the aortic cushions
(AoC). Arrowheads indicate points of contact be-
tween ECs and the aortic lumen. Vessels connect-
ing the peritruncal plexus with the main coronary
plexus are not observed until approximately E12.5–
E13.0 (arrows in C). RV, right ventricle. Scale bars
represent 100 mm. See also Figure S4.2013a; Waldo et al., 1990), and the peritruncal plexus was now
fully connected to the main coronary capillary network. A day
later, at E14.5, multiple aorta-contacting vessels were still
observed in some hearts (e.g., on the right side of the aorta,
shown in Figure S4D, in contrast with the major vessel on the
left side), but by E15.5, these vessels had resolved into a single
major lumenized vessel on either side of the aorta, generally
positioned at the level of the aortic valve (data not shown).
Peritruncal ECs in Cxcl12-Null Hearts Are Impaired in
Their Ability to Anastomose with the Aortic Lumen
Peritruncal plexus development was then examined in Cxcl12
mutants. At E11.5, striking peritruncal plexus abnormalities
were observed in five of seven mutants examined (71%). In the
examples shown in Figures 5B and 5C, clusters of ECs were
observed in the sub-epicardial layer of the OT (bracketed re-
gions); however, the ECs lacked processes contacting the aortic
lumen, in contrast to controls (n = 6; Figure 5A). In addition, in
each mutant, a short vessel protruded from the lumen of the OT
(asterisks in Figures 5B and 5C). Dramatic differences were
also observed at E12.5. Where EC strands in control aortas
were observed to formmultiple anastomoses on the left and right
sides of the lumen (n = 12; Figure 5D), all Cxcl12mutants (n = 11)
were characterized by reduced or absent peritruncal EC connec-
tions. In many cases, a single contacting vessel/EC strand was
present (7 of 11), and peritruncal EC strands/clusters were
frequently localized solely in the sub-epicardial layer of the aorta
(Figures 5E and 5F). Similar results were observed at E13.5 and
E14.5 (Figure S4). Sections through the OT at E12.5 confirmed
that peritruncal ECs were not absent in Cxcl12 nulls but rather
were mislocalized in sub-epicardial clusters and lacked anasto-
motic connections with the aortic endothelium (Figures 5H and
5J). This was in contrast to controls, where anastomosing EC
strands were localized in close proximity to the aortic lumen (Fig-
ures 5G and 5I). A recent study has shown that endocardial
sprouts can extend from the aortic lumen and make a small
contribution to the future CA stems (Chen et al., 2014a). We
also observed sprouts from the aortic lumen in 33% of wild-
type E12.5 hearts examined (Figure 5K); however, sprouts were
wider in diameter and more frequently observed in Cxcl12 nulls
(66% of nulls; Figures 5J and 5L) and could be both proximally
andmuchmoredistally positioned relative to the aortic valve (Fig-
ure 5L). Quantification of the number of peritruncal aortic connec-Devetions showed a significant reduction in Cxcl12 nulls, even when
the more proximal sprouts were included (Figure 5M).
Targeting Cxcl12 in Ventricular Myocardium Is
Insufficient to Induce CA Defects
The defects we observed in Cxcl12 nulls suggest that CXCL12 is
required for anastomosis of peritruncal ECs in the aorta but not
for the initial establishment of the peritruncal plexus. This role
for CXCL12 signaling correlates with its high level of expression
in the developing aorta. However, Cxcl12 is also expressed in
the ventricular myocardium, and we wanted to determine
whether this domain of Cxcl12 expression is also important in
CA development. For example, ventricular CXCL12 could play
a direct role in the remodeling of the vessel network, perhaps
by modulating EC proliferation in response to coronary flow.
We used two different Cre drivers in conjunction with a floxed
Cxcl12 allele (Greenbaum et al., 2013) in an attempt to differen-
tially target aortic and ventricular myocardial expression of
Cxcl12. Nkx2.5-Cre is an established driver in cardiac chamber
cardiomyocytes (CMs) and is now known to be active in both first
andsecondheart fields (FHFandSHF, respectively), although the
extent and degree of expression in the SHF is likely to be reporter
andgenetic backgrounddependent (Maet al., 2008;Moseset al.,
2001). For example, a recent study using the same Nkx2.5-Cre
allele as that used here showed inefficient recombination in the
OT (Ramsbottom et al., 2014). The Mef2c enhancer Cre drives
recombination in anterior SHF lineages (Verzi et al., 2005) but
would not be expected to effect recombination in left ventricular
wallmyocardium (Figure 6A). Analysis ofCxcl12 expression in the
conditional mutants showed that, as expected, Nkx2.5-Cre effi-
ciently knocked down Cxcl12 in the ventricular muscle (Fig-
ure 6B’) but had much less effect in the OT (Figure 6C’).
Conversely, Mef2c-Cre was able to substantially reduce (but
not completely abrogate) Cxcl12 expression in the OT, particu-
larly the proximal portion (Figure 6E’), and knock it out in the right
ventricle and IVS while leaving left ventricular wall expression
largely intact (Figure 6D’). Targeting in the right ventricle was
not completely effective, as residual expression was observed
at the base of the pulmonary trunk (arrow in Figure 6D’).
The twoconditionalmutants showed remarkably different phe-
notypes. While normal CAs and ostia were present in Nkx2.5-
Cre;Cxcl12fl/ mutant hearts (n = 8) (Figures 6F–6G’), with no
apparent difference in CA length (Figure 6H), a range of muchlopmental Cell 33, 455–468, May 26, 2015 ª2015 The Authors 461
Figure 5. Defective Anastomosis of the Peritruncal Plexus in Cxcl12-Null Hearts
(A–F) Confocal microscopic images of E11.5–E12.5 whole-mount PECAM-labeled control andCxcl12/ hearts showing the OT/aorta (Ao) and peritruncal plexus
(bracketed region). (A–C) Images at E11.5. Arrowheads indicate multiple points of contact between ECs and OT in the control, shown in (A). In contrast, EC
clusters localized in the sub-epicardial region of Cxcl12 nulls lack connections with the OT lumen, shown in (B and C); asterisks indicate vessels that appear to
sprout from the OT lumen of nulls. (D–F) At E12.5, Cxcl12 nulls (E and F) show reduced/absent peritruncal EC anastomoses (arrowheads) on both sides of the
aorta, compared to controls (D); disconnected EC strands/clusters (blue arrowheads in E and F) and sub-epicardially localized vessels (arrow in F) are also
observed in nulls. Dotted lines delineate the edges of the aortic cushions (AoC).
(G–J) PECAM/DAPI-stained sections (20 mm) show anastomoses (arrowheads, G and I) formed by peritruncal ECs in control hearts. Null sections lack anas-
tomoses, and ECs are clustered away from the aortic lumen (white ovals in H and J). Arrow in (J) indicates a possible sprout from the aortic lumen.
(legend continued on next page)
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more severe phenotypes was observed in Mef2c-Cre;Cxcl12fl/
mutant hearts (n = 9) (Table 1). CA abnormalities were seen in
six mutants, including absent LCA and left ostium in four cases
(Figures6I–6K’). In addition, onemutant exhibitedCAsoriginating
from the pulmonary trunk and the portion of right ventricle imme-
diately proximal to the pulmonary valve (Figures 6L–6N), while in
another mutant, both CAs branched from the right ostium (Fig-
ures S5G–S5L). These were frequently, but not always, accom-
panied by SLV defects (Figures S5A–S5C), which themselves
could be variable in their severity (Figures S5D–S5F). SLV defects
were observed in only two Nkx2.5-Cre;Cxcl12fl/ mutants (an
example is shown in Figure 6G’’). The defects of CA formation
and patterning observed in the Mef2c-Cre;Cxcl12fl/ mutant,
but not the Nkx2.5-Cre;Cxcl12fl/ mutant, indicate that it is
CXCL12 secretedby the aorta rather than the ventricularmyocar-
dium that plays the most significant role in CA development.
DISCUSSION
We have identified a crucial role for the CXCL12/CXCR4 axis in
the development of the CAs. Confocal analysis of the OT at the
earliest stages of CA stem development enabled us to identify
abnormalities in the structure of the peritruncal plexus, the
aortic capillary network from which the CA stems first develop.
Peritruncal ECs were mislocalized and failed to connect to the
aortic endothelium in Cxcl12 mutants, resulting in defective CA
stem development. Furthermore, although we showed Cxcl12
and Cxcr4 expression throughout the heart (in myocardium
and ECs, respectively), conditional mutagenesis experiments
identified the aorta as the source of CXCL12 critical for CA devel-
opment. We propose that CXCL12 acts early in CA formation,
guiding peritruncal plexus ECs toward the aortic lumen to
form anastomoses, consistent with the known role of CXCL12/
CXCR4 signaling in chemoattraction and guidance of collective
cell movements. Failure of this process results in absent or
abnormally positioned coronary stems and ostia, as well as
a subsequent lack of intra-ventricular CAs in late-gestation
embryos.
Our confocal analysis of the OT of developing hearts revealed
the characteristic structure of the peritruncal capillary network,
which connects specifically to the aorta. This appears to develop
as a separate plexus from E11.5, arising from vessels in the sub-
epicardial region of the aorta and initially unconnected to the
main intra-ventricular coronary plexus. This contrasts somewhat
with previous studies that describe a ring of coronary vessels
that surround the entire outflow region and grow toward the
aorta (Ando et al., 2004; Bernanke and Velkey, 2002; Waldo
et al., 1990). However, this difference could be accounted for
by the earlier developmental stages at which we carried out
our analyses. The ability of CXCL12 to direct migration of various
cell types is well documented (Belmadani et al., 2005; Escot
et al., 2013; Kasemeier-Kulesa et al., 2010; Li et al., 2013;(K and L) Confocal microscopic images of whole-mount PECAM-labeled E12.5 he
(L) hearts. Both proximal and distal lumen sprouts can be observed in the null.
(M) Comparison of numbers of peritruncal EC anastomoses formed in E12.5 con
distal) sprouts from the aortic lumen were included in the data.
Data are presented as mean ± SD. All of the aforementioned images in (A)–(L) a
100 mm. See also Figure S4.
DeveSong et al., 2009; Theveneau et al., 2010), while the reduced
anastomoses and mislocalization of peritruncal ECs observed
in Cxcl12mutants are consistent with a lack of angiogenic guid-
ance cues in the OT resulting from deficient CXCL12 signaling.
The ectopic distal positioning of those vessels that managed to
form and contact the lumen in some Cxcl12mutants may simply
indicate the failure of anastomosis in the more proximal region of
the aorta and/or may point to abnormalities of proximo-distal EC
migration. However, it is not yet understood how the broad
expression of Cxcl12 in the aorta could correlate with this fine-
tuning of CA stem positioning; this likely involves additional mo-
lecular signals, adding another layer of complexity to the process
(discussed later).
In some Cxcl12 nulls, single, high coronary ostia were associ-
ated with short proximal CAs that failed to branch. It is possible
that, in contrast to normal vessels, these result from sprouting
from the aortic endothelium, as large-diameter sprouting vessels
were frequently observed in Cxcl12 mutants both proximal and
distal to the aortic valve. Endothelial sprouts were also observed
in normal hearts, in agreement with the recent demonstration of a
limited role for aortic sprouting in normal CA stem formation
(Chen et al., 2014a) and in contrast to the accepted ingrowth
model. It is feasible that this mechanism is over-activated in
Cxcl12 nulls in an attempt to compensate for the lack of anasto-
mosis from peritruncal vessels. Although this is speculative, it
could be tested by lineage tracing using a Cre driver specific
for the endocardial lining of the aorta, such as Nfatc1 (Wu
et al., 2012). It is also unclear why the compensatory proximal
stemswould be unable to connect themain coronary plexus, un-
less this process also requires CXCL12-dependent migration of
the latter toward the aorta.
Another explanation for the failure of the proximal CA stems to
grow into the ventricles in the Cxcl12mutants could be that dis-
rupted blood flow resulting from the abnormally distal ostia,
combined with the defective aortic valve, reduces the hemody-
namic forces associated with blood entering the CAs. Shear
and strain forces induced by diastolic blood flow are generally
accepted to act as a necessary stimulus to CA remodeling,
causing an increase in vessel lumen size and inducing smooth
muscle recruitment (Jones et al., 2006; Ratajska and Fiejka,
1999; Tomanek, 2005). However, the positioning of the coronary
ostia has been shown to vary considerably in wild-type mouse
hearts (Ferna´ndez et al., 2008) without causing disruption in
intra-ventricular CA development, making this possibility less
likely.
Finally, these CA stems could, in theory, form by normal
means—i.e., peritruncal EC anastomosis—with the failure of
the intra-ventricular CAs to mature resulting from an additional,
ventricle-specific requirement for CXCL12-CXCR4 signaling.
However, when ventricular expression of Cxcl12 was targeted
while expression in the aorta was left mostly intact (Nkx2.5-Cre
conditional mutants), we did not observe major defects in CAarts show vessels sprouting from the aortic lumen (arrows) in control (K) and null
trols (Con; blue columns) versus Cxcl12 nulls (gray columns). Proximal (but not
re maximum intensity z projections of confocal stacks. Scale bars represent
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Figure 6. Targeting Cxcl12 Expression in the OT Has a Severe Impact on CA Development
(A) Schematic of hearts comparing regions of Cxcl12 (blue) and Cre recombinase (as indicated by published lineage tracing) expression driven by either Nkx2.5
(red/pink) or Mef2c (green). Relative expression levels are indicated by shading. Ao, aorta; PT, pulmonary trunk, LV, left ventricle; RV, right ventricle. LV, left
ventricle.
(B–E’) Cardiac expression of Cxcl12 was targeted using Nkx2.5 and Mef2c Cre drivers. In situ hybridizations (E14.5, heart sections) show effective targeting of
Cxcl12 expression by Nkx2.5-Cre in the ventricles (B’) but not the aorta (C’). Control sections are shown in (B) and (C). Mef2c-Cre largely abrogated Cxcl12
(legend continued on next page)
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Table 1. CA and SLV Defects inMef2c-Cre;Cxcl12fl/– Mutant
Hearts
Mutant LCA RCA Ostia SLV Defects
1 X U right ostium only U
2 X U right ostium only U
3 Xa U right ostium only X
4 X U right ostium only U
5 U U LCA and RCA branch from
right ostium
partialb
6 U U LCA and RCA connect to
RV and PT, respectivelyc
U
7–9 U U left and right ostia U
X indicates that no defects were detected. PT, pulmonary trunk; RV, right
ventricle.
aCAs were observed in the ventral portion of the LV, branching from a CA
located in the IVS.
bLeft aortic valve leaflet was normal.
cA third ostium was formed by a CA arising from the IVS and connecting
to the aorta.development. This seems to preclude a significant role for ven-
tricular CXCL12 in CA development, although analysis of greater
numbers may be required to uncover a more subtle role, e.g., in
CA growth.
Targeting of Cxcl12 expression in the aorta (Mef2c-Cre) had a
considerably more profound impact on CA development, with
absent and mispatterned coronary ostia indicating a disruption
of CA stem formation. The reduced penetrance and severity of
CA defects seen in the Mef2c conditional, compared to full,
Cxcl12 nulls was not unexpected, as patches of low level
Cxcl12 expression remained in and around the OT in addition
to the untargeted left ventricular expression. However, it is worth
noting that left ventricular Cxcl12 was not sufficient to rescue
LCA formation in a number of conditional mutants, underlining
the critical role of OT-specific Cxcl12 expression in CA stem for-
mation. Intriguingly, one mutant exhibited CAs connected to
the pulmonary trunk. This is an unusual phenotype, although a
similar scenario has been observed in a rare but serious human
congenital cardiac anomaly known as anomalous origin of the
LCA from the pulmonary artery (ALPACA) (Hauser, 2005; Wes-
selhoeft et al., 1968). Peritruncal vessels do not normally pene-
trate the pulmonary trunk for reasons that are not well under-
stood, but may involve differential gene expression (Bernanke
and Velkey, 2002; Gonza´lez-Iriarte et al., 2003). Clearly, expres-
sion of Cxcl12 is insufficient to regulate this differential invasionexpression in the right ventricle and IVS (D’); arrow in (D’) indicates residual Cxc
reduced in both proximal (bracketed) and distal regions of the aorta (E’). Control
(F–G’’) Labeling with anti-SM22a antibody shows normal CAs and ostia in Nkx2.
infrequently (G’’); asterisks indicate thickened aortic valve leaflets. Controls are s
(H) Scatter graph shows the relative length of LCAs and RCAs in control and Nkx
conditional nulls, with no overall difference between the two groups.
(I–N) CA defects in Mef2c-Cre;Cxcl12fl/ hearts; arrows indicate CAs. Absence o
Arrowhead in (K’) indicates an IVS vessel that branches from the RCA. (I) Control w
free wall. (J’) Example of one mutant with CAs formed within right ventricle free wa
trunk (arrow in N) and the right ventricle, just proximal to the pulmonary trunk val
ostium was formed in the aorta of the same mutant by a CA that branched into t
Scale bars represent 100 mm. See also Figure S5.
Deveof the aorta, as it is expressed at equally high levels in the aorta
and the pulmonary trunk; therefore, repulsive factors preventing
EC migration toward the pulmonary trunk may also contribute. It
is not known how such repulsion is overcome in the Mef2c-cre
Cxcl12 conditional mutant, but it is possible that uneven recom-
bination of the floxedCxcl12 allele in theOT, leading to an altered
balance of CXCL12 in the outflow vessels, may play a role.
Together with the observation of CA branches from the IVS
growing into the ventral portion of the left ventricle (in the
absence of a left ostium; Table 1), our results suggest that
compensatory mechanisms of CA development are induced
when normal CA stem development fails, perhaps facilitated
by residual Cxcl12 expression in the conditional hearts.
SLV defects were always observed in Cxcl12 knockouts and
frequently associated with the conditional null phenotype
(SM22a-cre, Mef2c-Cre, and, to a much lesser extent, Nkx2.5-
Cre). Although we did not investigate the basis of the valve
defects in this study, a role in endothelial-to-mesenchymal trans-
formation (Endo-MT) seems likely, as Cxcr4 is expressed in the
endothelial lining of the cardiac cushions as well as in coronary
ECs. The second CXCL12 receptor, CXCR7 (Balabanian et al.,
2005; Burns et al., 2006), is also expressed in the endocardial lin-
ing of the OT, while SLV defects have been identified in Cxcr7
mutants (Sierro et al., 2007; Yu et al., 2011). Therefore, a com-
bined role for CXCR4 and CXCR7 in valve formation might be
expected.
While this article was in its revision stages, the K. Red-Horse
laboratory published a study describing the role of VEGF-C in
peritruncal vessel growth and described a capillary plexus they
termed the ‘‘aortic sub-epicardial vessels,’’ or ASVs, which circle
the lateral side of the aorta, expanding as development pro-
ceeds, and connect to the aortic lumen (Chen et al., 2014a).
We believe that these ASVs are continuous with the peritruncal
vessels we describe, as we have also observed superficial ves-
sels on the ventral side of the aorta connecting to the deeper
peritruncal vessels (data not shown). However, we focused our
attention more closely on the vessels deep in the aortic wall
that, we consider, form the critical connections with the lumen.
Chen et al. showed that VEGF-C is required for the initial growth
and expansion of the peritruncal vessels andwent on to describe
a population of CMs specific to the aorta. The CMs are predicted
to provide the angiogenic signal required for anastomosis of the
peritruncal vessels with the aortic endothelium, as well as play-
ing a role in patterning the CA stems (Chen et al., 2014a). Our re-
sults show that while CXCL12 provides an angiogenic signal for
peritruncal ECs, its expression is not restricted to this minor pop-
ulation of CMs described; therefore, it is unlikely to be whollyl12 expression at the base of the pulmonary trunk. Cxcl12 was considerably
sections are shown in (D) and (E).
5-Cre;Cxcl12fl/ hearts (arrows in F’, G’, and G’’). SLV defects were observed
hown in (F) and (G).
2.5-Cre;Cxcl12fl/ hearts. Relative CA length was variable in both controls and
f the LCA and left ostium (I’ and K’) was observed in several conditional nulls.
ith CAs visible in left ventricle free wall. (J) Control with CAs in right ventricular
ll. (L–N) In oneMef2c-Cre;Cxcl12fl/ heart, CAs originated from the pulmonary
ve (arrows in M and M’). Boxed region in (M) is shown enlarged in (M’). A third
he IVS (arrowhead in L).
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responsible for the fine positioning of the stems. Thus, we reason
that the aortic CMs may secrete an additional factor that co-op-
erates with CXCL12 or perhaps serves to antagonize anti-angio-
genic signals acting in the walls of the OT, as suggested in Chen
et al.’s report. So far, preliminary analyses of Cxcl12 null OTs
have not revealed major differences in the distribution of CMs
(data not shown), although further investigation is required. The
recent work on VEGF-C adds to previous reports by Tomanek
and colleagues of a requirement for VEGF signaling in CA stem
formation (Tomanek et al., 2002, 2006). Taken together, the com-
bined data suggest a model of CA stem formation whereby
VEGF-C and CXCL12 act sequentially to direct growth and anas-
tomosis of the peritruncal vessels, respectively.
Our results have shown that the CXCL12/CXCR4 signaling
pathway plays an essential role in CA development; failure of ar-
teriogenesis in Cxcl12 and Cxcr4 mutant hearts most likely ex-
plains the lethality caused by loss of either gene. Our data
showing the role of CXCL12 in the anastomosis of peritruncal
ECs provide insight into the molecular processes that control
the earliest stages of CA development, which could potentially
inform future therapeutic interventions to regenerate coronary
vessels and effect cardiac repair. For instance, sequential, timed
activation/repression of multiple signaling pathways, including
CXCl12, e.g., using modified RNAs (Zangi et al., 2013), may
well bemore effective at inducing neovascularization of ischemic
tissue than treatment with a single effector.
EXPERIMENTAL PROCEDURES
Mutant Mouse Breeding
Cxcl12 mutants (Cxcl12-GFP; Ara et al., 2003) and Cxcl12fl/fl (Greenbaum
et al., 2013), Cxcr4fl/fl (Nie et al., 2004), Tie2-Cre (Kisanuki et al., 2001),
SM22a-Cre (Holtwick et al., 2002), Nkx2.5-Cre (Moses et al., 2001), and
Mef2c-Cre (Verzi et al., 2005) mice have been described previously. Genera-
tion of Cxcr4 nulls and Cxcr4 and Cxcl12 conditional mutants is described in
the Supplemental Experimental Procedures. Animal work was carried out ac-
cording to UK Home Office regulations.
Immunolabeling
For whole-mount immunolabeling, hearts were permeabilized in PBS with
0.1% Tween 20 (PBST), blocked for 1 hr in PBST/10% goat serum, and incu-
bated overnight at 4C with primary antibody in blocking buffer. Primary an-
tibodies anti-PECAM-1 (Mec13:3, Pharmingen) and anti-SM22 a (Abcam)
were diluted in blocking buffer at 1:50 and 1:250, respectively. Hearts were
washed several times in PBST (1-hr washes) before incubation overnight
at 4C with secondary antibody (Alexa Fluor 594 conjugate, Life Technolo-
gies). Fluorescent images were captured on a Zeiss Axio Lumar.V12
stereomicroscope.
Immunolabeling of 10-mm paraffin sections and 12-mm frozen sections was
carried out according to standard protocols. Briefly, sections were incubated
in blocking buffer for 1 hr at room temperature (PBS/10%BSA/1% goat serum
for wax sections and PBS/10% BSA/10% goat serum/0.1% Triton X-100 for
cryosections) followed by primary antibody in blocking buffer at 4C overnight.
Secondaries were Alexa Fluor conjugated antibodies (Life Technologies, Ab-
cam, Jackson ImmunoResearch), and DNA was counterstained using DAPI
(Sigma). Images were captured on a Zeiss Axioimager Z1 microscope. Further
details, including details of antigen retrieval and antibodies used, can be found
in Supplemental Experimental Procedures.
HREM
Embryos were bled out for 5 min, and then hearts were dissected out and fixed
for 30min in 4%paraformaldehyde. The hearts were then rocked in a large vol-
ume of water for 60 min (with three or four changes of water) to lyse the blood
cells and transferred back to fix. HREM was carried out as described else-466 Developmental Cell 33, 455–468, May 26, 2015 ª2015 The Authowhere (Mohun and Weninger, 2012). See also Supplemental Experimental
Procedures.
In Situ Hybridization
In situ hybridization was carried out on 10-mmparaffin sections using standard
methods. Hybridization temperature was 70C. Digoxigenin-labeled probes
for Cxc12 and Cxcr4 were synthesized from full-length IMAGE clones
(IMAGE:3483088 and IMAGE:3592479, respectively). See Supplemental
Experimental Procedures for further details.
Confocal Analysis
Immunolabeled hearts from control (wild-type or Cxcl12+/) and Cxcl12/
(E12.5–E15.5) embryos were dehydrated through a methanol series before
clearing with one part benzyl alcohol/two parts benzyl benzoate solution
(BABB; Sigma). Embryos were examined by epifluorescence on an inverted
LSM710 confocal system mounted on an AxioObserver Z1 microscope (Carl
Zeiss, UK). See Supplemental Experimental Procedures for further details.
Statistical Analysis
When comparing the number of anastomoses formed with the aortic lumen in
Cxcl12 nulls versus controls, we calculated statistical significance using an un-
paired Student’s t test. Significance was accepted when p < 0.05.
Quantification of Relative CA Length
E16.5 hearts in paraffin wax were sectioned at 12 mm and stained with anti-
SM22a antibody to label smooth muscle cells. The length of the CAs relative
to the total distance from the left or right ostium to the tip of each heart was
calculated as follows: the number of sections from the tip of the heart to the
left or right coronary ostium was multiplied by the section thickness, giving a
‘‘heart length’’ figure. The number of consecutive sections with visible
SM22a-stained arteries in the left or right ventricles was similarly multiplied
by the section thickness and subsequently divided by heart length to give a
relative measure of CA length.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2015.03.026.
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